MedPath

Combined Intense Pulsed Light (IPL) With Fractional Erbium:YAG Laser Ablation in Scar Prevention

Not Applicable
Conditions
Intense Pulsed Light
Erbium-yttrium Aluminum Garnet Laser
Scar Prevention
Interventions
Device: Intense pulse light
Registration Number
NCT04722705
Lead Sponsor
Hallym University Kangnam Sacred Heart Hospital
Brief Summary

The scar site was divided into 3 sites; combined IPL/fractional Er:YAG laser treatment site, fractional Er:YAG laser treatment site and untreated control site. At baseline, three lesions were randomized to IPL / fractional Er:YAG laser combination therapy site, fractional Er:YAG laser treatment alone site, and untreated control site. The laser treatment was conducted total three sessions, immediately at suture removal (baseline), 4 weeks after suture removal and 8 weeks after suture removal. The evaluation of scar site was conducted 3 months later after last treatment (20 weeks after suture removal).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Clinical diagnosis of postoperative scars on the abdomen
  • scars were symmetrical shaped in a line of 3cm or more
Exclusion Criteria
  • uncontrolled systemic or chronic disease
  • hypersensitive to the ingredients
  • a history of other laser treatments within the past 6 months
  • pregnancy
  • lactation
  • Recent sun exposure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
combined IPL/fractional Er:YAG laser treatment siteIntense pulse lightAt baseline, three lesions were randomized to IPL / fractional Er:YAG laser combination therapy site. Topical anesthetic cream was applied to the scar 30 minutes before laser treatment. The same dermatologist performed all laser treatments including IPL and 2,940 nm Er:YAG fractional laser. The face was cooled after treatment with gauze soaked in ice water. The laser treatment was conducted total three sessions, immediately at suture removal, 4 weeks after suture removal and 8 weeks after suture removal. The evaluation of scar site was conducted 3 months later after last treatment.
Primary Outcome Measures
NameTimeMethod
Patient Observer Scar Assessment Scale20 weeks

The POSAS observer consists of following 6 items: vascularity, pigmentation, thickness, surface area, relief, pliability. Each item was evaluated on a scale from 1 (normal skin) to 10 (worst scar). Finally, the POSAS total score was calculated as the sum of six items, ranging from 6 to 60.

Secondary Outcome Measures
NameTimeMethod
Total Vancouver Scar scale20 weeks

The VSS consists of 4 following components: vascularity, pigmentation, height ranging from 0 to 3, and pliability from 0 to 5. Score zero means the normal skin, while maximum scores indicate the worst scar.

Erythema index20 weeks

The indexes were measured by placing Spectrophotometer (Cortex Technology, Had- sund, Denmark) directly on the skin lesions for two minutes in the room with constant temperature (20\~24 degree Celsius) and humidity (28\~38 percent).

This measurement was performed to determine erythema.

Melanin index20 weeks

The indexes were measured by placing Spectrophotometer (Cortex Technology, Had- sund, Denmark) directly on the skin lesions for two minutes in the room with constant temperature (20\~24 degree Celsius) and humidity (28\~38 percent).

This measurement was performed to determine pigmentation.

Trial Locations

Locations (1)

Kangnam Sacred Heart Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath